Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
33.10
-1.15 (-3.36%)
May 6, 2026, 5:00 PM CET
Market Cap628.67M +8.4%
Revenue (ttm)371.13M +7.3%
Net Income813.00K
EPS0.04
Shares Out18.36M
PE Ratio773.28
Forward PE27.62
Dividendn/a
Ex-Dividend Daten/a
Volume24,413
Average Volume51,167
Open33.90
Previous Close34.25
Day's Range32.75 - 34.25
52-Week Range26.50 - 49.40
Beta0.12
RSI45.69
Earnings DateMay 21, 2026

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 691
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements